Cell/Gene Tx channel feed

Months af­ter an­oth­er lethal set­back, Juno fi­nal­ly opts to kill lead CAR-T

9 years ago
R&D

A bet­ter gene ther­a­py vec­tor out of Har­vard is cred­it­ed with restor­ing nor­mal hear­ing in mice

9 years ago

In wake of a CAR-T re­struc­tur­ing, No­var­tis says it’s ready to hunt a pi­o­neer­ing OK for lead pro­gram

9 years ago
R&D

Spark’s de­liv­ery vec­tor trig­gers an­oth­er trou­bling im­mune re­ac­tion, but R&D team main­tains he­mo­phil­ia B ef­fi­ca­cy

9 years ago

Blue­bird, Cel­gene jump off to a promis­ing start in the marathon race to de­vel­op a CAR-T for mul­ti­ple myelo­ma

9 years ago
R&D

Kite grabs a stem cell bi­ol­o­gy ‘break­through’ in race for off-the-shelf T cell ther­a­pies

9 years ago
R&D
First page Previous page 56575859
A service from the Financial Times